TypeName: Business Offer
Country: United States
Summary: "Dalbavancin is a semi-synthetic glycopeptide by introducing a positively charged lipophilic
moiety in a previously unexplored region of the natural glycopeptide. This modification provides a longer in vivo half life, and improved in vitro activity against a variety of Gram positive and multi-drug resistant isolates such as MRSA and MRSE."
https://www.bocsci.com/dalbavancin-cas-171500-79-1-item-169772.html
Description: We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals. Our complete suite of CRO services spans the entire molecule development pipeline including contract research for target identification, building blocks, compound synthesis, biochemical and cellular analysis, preclinical animal tests, and clinical studies.
OfferId: 2239
Name:Alex Brown
Telphone: